
1. J Clin Immunol. 2021 Feb;41(2):470-472. doi: 10.1007/s10875-020-00913-4. Epub
2020 Nov 13.

Novel Compound Heterozygous Mutations in ZAP70 Leading to a SCID Phenotype with
Normal Downstream In vitro Signaling.

Kaman K(1)(2), Abrams M(3), Dobbs K(4), Notarangelo LD(4), Delmonte OM(4),
Palterer B(5)(6), Pai SY(7)(8), Johnston A(3).

Author information: 
(1)Department of Pediatrics, UMMS-Baystate, Springfield, MA, USA.
kelseykaman@gmail.com.
(2)Department of Allergy and Immunology, Yale University, CT, New Haven, USA.
kelseykaman@gmail.com.
(3)Department of Pediatrics, UMMS-Baystate, Springfield, MA, USA.
(4)Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, 
USA.
(5)Department of Experimental and Clinical Medicine, University of Florence,
Largo Brambilla 3, 50134, Florence, Italy.
(6)Flow Cytometric Diagnostic Centre and Immunotherapy, Careggi University
Hospital, Florence, Italy.
(7)Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston,
MA, USA.
(8)Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA,
USA.

DOI: 10.1007/s10875-020-00913-4 
PMID: 33184721 

